Combined use of painkillers, antidepressants may increase bleeding risk
the ONA take:
According to a study published this week in The BMJ, researchers have found that combined use of antidepressants and NSAID painkillers is associated with an increased risk of bleeding.
For the study, researchers analyzed data from more than 4 million people who were prescribed antidepressants between 2009 and 2013 included in the Korean nationwide health insurance database. Researchers compared the time to first admission with intracranial hemorrhage within 30 days of a new prescription among patients with antidepressants and NSAIDs compared with those with only antidepressants.
Results showed a substantially increased bleeding risk among those who took both prescription medications. Moreover, there was no statistically significant difference in risk of bleeding with age or different classes of antidepressant medications. Male gender was also found to be associated with a higher risk of bleeding among those who were prescribed the combination.
The authors note that their results may have been impacted by other factors and caution is advised when interpreting the results; however, health care professionals should use caution in patients who are prescribed both types of medications.
Researchers have found that combined use of antidepressants and NSAID painkillers is associated with an increased risk of bleeding.
Sign Up for Free e-newsletters
- A Witness to Letting Go: Nursing Care at the End of Life
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Risk for Cardiovascular Disease Higher in Survivors of Testicular Cancer
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- Age Not a Deterrent to Immunotherapy for Malignant Melanoma
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Patients With Head and Neck Cancer Have Greater Chance of Being Prescribed Opioids
- Medical Terms in Patient Education: Using the Confusing to Explain the Complicated
- Bedside Assessment Tool Improves Worst Pain in Patients With Cancer
- Androgen-Deprivation Therapy for Prostate Cancer May Cause Nocturia, Sleep Disturbance
- USPSTF Rates Ovarian Cancer Screening a D for Asymptomatic, Low-Risk Women
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|